Onderzoeker
Tom Vanden Berghe
- Disciplines:Biofysica, Moleculaire en celbiologie, Laboratoriumgeneeskunde, Microbiologie, Systeembiologie, Plantenbiologie, Medicinale en biomoleculaire chemie
Affiliaties
- Vakgroep Biomedische Moleculaire Biologie (Departement)
Lid
Vanaf1 okt 1999 → Heden
Projecten
1 - 5 of 5
- Onderzoek naar de immunoregulatorische eigenschappen van ferroptose in experimentele kankermodellenVanaf1 nov 2020 → HedenFinanciering: FWO mandaten
- Therapeutische verkenning van loodferroptoseremmers bij multiple sclerose - subsidie 2020Vanaf1 jan 2020 → 30 jun 2021Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Therapeutische verkenning van loodferroptoseremmers bij multiple scleroseVanaf1 jan 2019 → 31 dec 2020Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Gebaseerde nanodeeltjes ferroptose inductie voor de behandeling van neuroblastoma en glioblastomaVanaf1 jan 2019 → 31 dec 2021Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Studie van de in vivo rol van effector caspasen in (patho-)fysiologische modelsystemen.Vanaf1 okt 2007 → 30 sep 2013Financiering: BOF - Andere acties, FWO mandaten
Publicaties
21 - 30 van 104
- Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids(2019)
Auteurs: Tom Vanden Berghe
Pagina's: 83 - 98 - To NET or not to NET : current opinions and state of the science regarding the formation of neutrophil extracellular traps(2019)
Auteurs: Sebastian Boeltz, Poorya Amini, Hans-Joachim Anders, Felipe Andrade, Rostyslav Bilyy, Simon Chatfield, Iwona Cichon, Danielle Clancy, Jyaysi Desai, Tetiana Dumych, et al.
Pagina's: 395 - 408 - Expression of receptor interacting protein kinase-3 and mixed lineage kinase domain-like protein in patients with COPD(2019)Volume: 199
Auteurs: Fien Verhamme, Hannelore Van Eeckhoutte, T Buyle-Huybrecht, Peter Vandenabeele, Tom Vanden Berghe
Aantal pagina's: 1 - Survival of single positive thymocytes depends upon developmental control of RIPK1 kinase signaling by the IKK complex independent of NF-κB(2019)
Auteurs: Louise V Webb, Alessandro Barbarulo, Jelle Huysentruyt, Tom Vanden Berghe, Nozomi Takahashi, Steven Ley, Peter Vandenabeele, Benedict Seddon
Pagina's: 348 - 361 - Water-soluble Withaferin A polymer prodrugs via a drug-functionalized RAFT CTA approach(2019)
Auteurs: Simon Van Herck, Benoit Louage, Raquel Pita Compostizo, Ruben De Coen, Tom Vanden Berghe, Bruno De Geest
Pagina's: 313 - 318 - Targeting ferroptosis to iron out cancer(2019)
Auteurs: Peter Vandenabeele, Tom Vanden Berghe
Pagina's: 830 - 849 - The molecular machinery of regulated cell death(2019)
Auteurs: Daolin Tang, Rui Kang, Tom Vanden Berghe, Peter Vandenabeele, Guido Kroemer
Pagina's: 347 - 364 - Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy(2019)
Auteurs: Filipe Elvas, Tom Vanden Berghe, Yves Adriaenssens, Peter Vandenabeele, Koen Augustyns, Steven Staelens, Sigrid Stroobants, Pieter Van der Veken, Leonie Wyffels
Pagina's: 4801 - 4824 - Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis(2018)
Auteurs: Pedro Henrique Viana Saavedra, Linyan Huang, Farzaneh Ghazavi, Stephanie Kourula, Tom Vanden Berghe, Nozomi Takahashi, Peter Vandenabeele, Mohamed Lamkanfi
- Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2(2018)
Auteurs: Alessandro Annibaldi, Sidonie Wicky John, Tom Vanden Berghe, Kirby N Swatek, Jianbin Ruan, Gianmaria Liccardi, Katiuscia Bianchi, Paul R Elliott, Samya Van Coillie, John Bertin, et al.
Pagina's: 566 - 580
Patenten
1 - 6 van 6
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- Targeting of Interleukin-1 and -18 in treatment of septic shock (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)